Welcome, Guest
Contact us  |   Careers  |  Open an Account  |  Site Map  |   Login    

Market

Mutual Fund
You are in Top performing Funds/Schemes
News View Snapshot Top performing Funds/Schemes New Funds in lime light FII Investment Knowledge Center
Here are the details of the schemes you searched for  UTI-Pharma & Healthcare Fund (G)

  Scheme Details
 
Asset Size (Cr.) Fund Mngr Launch Date Min. Inv Inc. Inv(Rs.)
89.34 Lalit Nambiar May 27 1999 5000 1000
  Latest Navs
 
Latest NAV Latest Dividend
42.16 0.00
  1 Year NAV Chart
 
Chart.

  Previous NAV
 
Date NAV (Rs.)
31 Dec 2010 42.16
30 Dec 2010 41.98
29 Dec 2010 41.72
28 Dec 2010 41.6
27 Dec 2010 41.44
  Asset Allocation
 
Type AssetValue
Equity 0
Debt 0
Others 0
  Return Summary
 

Scheme Name 3MONTH 6MONTH 1YEAR
Nifty 1.19 14.86 18.04
Sensex 1.59 15.19 17.56
UTI-Pharma & Healthcare Fund (G) 11.23 12.01 36.43
  Sectorial Allocation
 


No data available

  Previous Dividend
 
No data available
  Scheme Portfolio
 
Company %ofInv Inv Amt
Sun Pharma.Inds. 11.06 9.881
Lupin 10.71 9.5683
Dr Reddy's Labs 10.29 9.1931
Aurobindo Pharma 9.78 8.7375
Cipla 9.76 8.7196
  Contact Information
 
Address Phone Fax Website
UTI Towers, Gn Block,Bandra Kurla Complex,Bandra (East), Mumbai 400 051 022-66786666 022-26523031 www.utimf.com

Company Search

New Trading Platforms

  Insta Plus
  View Insta Plus Demo

Copyright©2010. All rights Reserved.
Equities: Equities transactions executed by Reliance Securities Limited | NSE SEBI Registration Number Capital Market :- INB 231234833 |BSE SEBI Registration Number Capital Market :- INB 011234839 | NSE SEBI Registration Number Derivatives :- INF 231234833 | Mutual Funds : Reliance Securities Limited | AMFI ARN No.29889
In case of any grievances/complaints please write to us at: grievance@rsec.co.in
This site is best viewed in 1024x768 and higher resolution.